LIND vs SRTA: stock comparison and AI forecast
Lindblad Expeditions Holdings, Inc. (LIND) and Strata Critical Medical, Inc. (SRTA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
LIND Lindblad Expeditions Holdings, Inc.
- Market Cap
- $2.07B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
SRTA Strata Critical Medical, Inc.
- Price
- $5.26 -1.3% · 6M
- Market Cap
- $465M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- LIND is 4.5 times larger than SRTA by market capitalization ($2.07B against $465M).
- Both companies share the SEC industry classification Transportation Services.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | LIND | SRTA |
|---|---|---|
| Market Cap | $2.07B | $465M |
| P/B Ratio | – | 1.68x |
| EPS | $-0.27 | $-0.29 |
| Book Value/Share | – | $3.12 |
| Revenue/Share | $13.10 | $2.68 |
| FCF/Share | $1.46 | $0.01 |
Profitability & Margins
| Metric | LIND | SRTA |
|---|---|---|
| ROE | – | -9.0% |
| ROA | – | -7.5% |
| ROIC | 10.8% | -5.8% |
| Gross Margin | 47.1% | 19.4% |
| Operating Margin | 7.5% | -6.9% |
| Net Margin | – | -10.5% |
| EBT Margin | 2.4% | -8.0% |
| Tax Rate | 51.7% | 0.0% |
Financial Health
| Metric | LIND | SRTA |
|---|---|---|
| Current Ratio | 0.76x | 2.77x |
| D/E Ratio | – | 0.19x |
| Financial Leverage | – | 1.19x |
| Interest Coverage | – | -4.3x |
| Working Capital | -$125M | $80M |
Cash Flow
| Metric | LIND | SRTA |
|---|---|---|
| Operating Cash Flow | $126M | $11M |
| Free Cash Flow | $96M | $810K |
| Capital Spending | -$30M | -$10M |
| OCF Growth YoY | 27.3% | – |
| FCF Growth YoY | 84.0% | – |
| FCF/Sales | 11.2% | 0.3% |
| CapEx/Sales | 3.5% | 4.2% |
Operational Efficiency
| Metric | LIND | SRTA |
|---|---|---|
| Asset Turnover | 0.76x | 0.72x |
| Receivables Turnover | – | 5.5x |
| Fixed Assets Turnover | 1.7x | 6.0x |
| Days Sales Outstanding | – | 66 days |
| Payables Period | 19 days | – |
Income Statement
| Metric | LIND | SRTA |
|---|---|---|
| Total Revenue | $860M | $237M |
| Operating Income | $65M | -$16M |
| Net Income | – | -$25M |
| R&D Expense | – | $3M |
| SG&A Expense | $270M | -$2M |
| Cost of Goods Sold | $455M | $191M |
Dividend & Shareholder Information
| Metric | LIND | SRTA |
|---|---|---|
| Shares Outstanding | 66M | 88M |
| Net Income Growth | – | -161.4% |
| EPS Growth | – | -176.3% |
LIND vs SRTA: stock comparison and AI forecast
Which is bigger, LIND or SRTA?
LIND is 4.5 times larger than SRTA by market capitalization ($2.07B against $465M).
Which one does Intratio's AI model rank higher, LIND or SRTA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.